Inhibitors of heat shock protein 70 (Hsp70) with enhanced metabolic stability reduce tau levels
[Display omitted] •Two series of YM-08 analogs were designed to remove metabolic liabilities.•Optimization resulted in JG-23, which is 12-fold more metabolically stable.•Compound JG-23 reduced total tau in two cell-based models. The molecular chaperone, Heat Shock Protein 70 (Hsp70), is an emerging...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 41; p. 128025 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
OXFORD
Elsevier Ltd
01.06.2021
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [Display omitted]
•Two series of YM-08 analogs were designed to remove metabolic liabilities.•Optimization resulted in JG-23, which is 12-fold more metabolically stable.•Compound JG-23 reduced total tau in two cell-based models.
The molecular chaperone, Heat Shock Protein 70 (Hsp70), is an emerging drug target for neurodegenerative diseases, because of its ability to promote degradation of microtubule-associated protein tau (MAPT/tau). Recently, we reported YM-08 as a brain penetrant, allosteric Hsp70 inhibitor, which reduces tau levels. However, the benzothiazole moiety of YM-08 is vulnerable to metabolism by CYP3A4, limiting its further application as a chemical probe. In this manuscript, we designed and synthesized seventeen YM-08 derivatives by systematically introducing halogen atoms to the benzothiazole ring and shifting the position of the heteroatom in a distal pyridine. In microsome assays, we found that compound JG-23 has 12-fold better metabolic stability and it retained the ability to reduce tau levels in two cell-based models. These chemical probes of Hsp70 are expected to be useful tools for studying tau homeostasis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2021.128025 |